Simon X. Benito's Insider Trades & SAST Disclosures
Simon X. Benito's most recent trade in Inovio Pharmaceuticals Inc was a trade of 2,917 Common Stock Options done . Disclosure was reported to the exchange on May 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Simon X. Benito.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 10,024 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 94,305 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 20 Jul 2022 | 2,000 | 77,305 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2022 | 2,000 | 4,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 20 Jul 2022 | 2,000 | 75,305 (0%) | 0% | 2.3 | 4,500 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 75,305 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 16 Mar 2022 | 2,000 | 57,305 (0%) | 0% | 3.2 | 6,320 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 2,000 | 6,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 16 Mar 2022 | 2,000 | 59,305 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 19 Jan 2022 | 2,000 | 59,305 (0%) | 0% | 2.2 | 4,400 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2022 | 2,000 | 8,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 19 Jan 2022 | 2,000 | 57,305 (0%) | 0% | 4.3 | 8,540 | Common Stock |
| Durect Corp | Simon X. Benito | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 07 Dec 2021 | 20,000 | 105,000 (0%) | 0% | 1.0 | 20,360 | Common Stock |
| Durect Corp | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 60,350 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 13 May 2021 | 3,045 | 57,305 (0%) | 0% | 6.6 | 20,158 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 16 Apr 2021 | 2,000 | 51,650 (0%) | 0% | 8.8 | 17,500 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 2,000 | 0 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 16 Apr 2021 | 2,000 | 53,650 (0%) | 0% | 3.6 | 7,120 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 16 Mar 2021 | 2,000 | 51,650 (0%) | 0% | 10.4 | 20,820 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 2,000 | 2,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 16 Mar 2021 | 2,000 | 53,650 (0%) | 0% | 3.6 | 7,120 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 16 Feb 2021 | 2,000 | 53,650 (0%) | 0% | 3.6 | 7,120 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 2,000 | 4,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 14.68 per share. | 16 Feb 2021 | 2,000 | 51,650 (0%) | 0% | 14.7 | 29,360 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 04 Jan 2021 | 2,750 | 54,400 (0%) | 0% | 3.6 | 9,790 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 04 Jan 2021 | 2,750 | 51,650 (0%) | 0% | 9 | 24,750 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 2,750 | 6,000 | - | - | Common Stock Options | |
| Durect Corp | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 55,000 | 55,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 20 May 2020 | 8,750 | 60,400 (0%) | 0% | 4.6 | 40,250 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2020 | 8,750 | 0 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Sale of securities on an exchange or to another person at price $ 15.95 per share. | 20 May 2020 | 8,750 | 51,650 (0%) | 0% | 16.0 | 139,594 | Common Stock |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 13,300 | 13,300 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 8,700 | 8,700 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2020 | 8,013 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Simon X. Benito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2020 | 8,013 | 51,650 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges